Carboxytherapy for Periorbital Dark Circles

November 2, 2021 updated by: Heba Mahmoud, Alexandria University

Evaluation of the Use of Carboxytherapy in Periorbital Dark Circles

the study evaluates carboxytherapy for the treatment of periorbital dark circles

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

two different concentrations of carboxytherapy administered to patients are compared regarding efficacy

Study Type

Interventional

Enrollment (Actual)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Alexandria, Egypt
        • Faculty of Medicine,Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy individuals with dark circles

Exclusion Criteria:

  • infections, scarring, pregnancy, allergy, on treatment for the condition.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Carboxy30
carboxy30
Other: Caboxy30
carboxy30 to periorbital dark halos
Other Names:
  • Carboxy30
Active Comparator: Carboxy60
carboxy60
Other: Caboxy60
carboxy60 to periorbital dark halos

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improvement of Melanin index
Time Frame: 6 weeks
change in melanin index of the dark circles
6 weeks
Improvement of erythema index
Time Frame: 6 weeks
change in erythema index of the dark circles
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Alexandria University

Investigators

  • Study Chair: Ossama H Roushdy, MD, University of Alexandria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2017

Primary Completion (Actual)

April 1, 2021

Study Completion (Actual)

May 15, 2021

Study Registration Dates

First Submitted

February 3, 2021

First Submitted That Met QC Criteria

February 6, 2021

First Posted (Actual)

February 9, 2021

Study Record Updates

Last Update Posted (Actual)

November 4, 2021

Last Update Submitted That Met QC Criteria

November 2, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 0104074

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Periorbital Disorder

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe